IGC Pharma IGC
NYSE IGC
$0.25 +0.00 (+0.20%)
As of: Oct 21, 2026 · 3:54 PM EDT

IGC Pharma (IGC) EV to CFO (2013 - 2016)

Updated

IGC Pharma's EV to CFO came in at 18.97 for Q1 2017.

Analysis

IGC Pharma (IGC) EV to CFO (2013 - 2016) Analysis & Trends

Over the trailing twelve months to Jun 30, 2016, IGC Pharma reported EV to CFO of 14.36; for FY2013, it was 33.67.

  • The Q1 2017 figure represents the highest quarterly EV to CFO since Q2 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 IGC Pharma 24.10 Mn 21.34 Mn 55,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2016 18.97
Sep 30, 2013 19.94
Jun 30, 2013 27.72
Mar 31, 2013 33.67
API Access

IGC Pharma EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=IGC&period=max&api_key=YOUR_API_KEY